Covid-19 w Brazylii - Redux

EN_01482351_0013

caption

Laboratory workers inspect vials of the CoronaVac vaccine, made by the Beijing-based company Sinovac, in S?o Paulo on May 29, 2021. The government's failure to acquire a large number of vaccines early this year left Brazil, which has surpassed the grim milestone of 500,000 COVID-19 deaths, vulnerable to an explosive second wave powered by more contagious variants. (Mauricio Lima/The New York Times)

special instructions

MINIMALNA CENA 100USD!!!

headline Covid-19 w Brazylii - Redux

created date 2021-05-29

credit MAURICIO LIMA/The New York Times Agency/East News

source The New York Times Agency

byline MAURICIO LIMA

original transmission reference 15532945

weight 1,91MB

size 28cm x 19cm przy 300dpi

keywords - Pokaż

000, 2021, 29, 500, A, ACQUIRE, AMERICA, AN, BEIJING-BASED, BRAZIL, BY, CASES, COMPANY, CONTAGIOUS, CORONAVAC, CORONAVIRUS, COVID-19, DEATHS, EARLY, EXPLOSIVE, FAILURE, GOVERNMENT, GRIM, HAS, IN, INFECTIONS, INSPECT, LABORATORY, LARGE, LEFT, LIMA, MADE, MAURICIO, MAY, MILESTONE, MORE, NEW, NUMBER, O, OF, ON, PANDEMIC, PAULO, POWERED, SECOND, SINOVAC, SOUTH, SPREAD, SURGE, SURPASSED, THE, THIS, TIMES, TO, VACCINE, VACCINES, VARIANTS, VIALS, VULNERABLE, WAVE, WHICH, WORKERS, YEAR, YORK,